在对纳胺的第12条MRL审查后,对确认数据的评估
EFSA journal. European Food Safety Authority
|July 24, 2023
概括
评估了napropamide残留的确认数据,只有葡萄的存储稳定性数据是令人满意的. 这导致了修订的最大残留量 (MRL),并证实没有消费者风险问题.
科学领域:
- 食品安全和农药法规的规定.
- 在农产品中的残留物分析.
背景情况:
- 欧普欧洲有限公司 (UPL Europe Ltd) 要求根据396/2005号法规对纳胺的确认数据进行评估.
- 发现了纳胺的数据缺口,包括新陈代谢,残留试验和分析方法.
研究的目的:
- 评估纳胺的新证实数据.
- 解决发现的数据缺口并修订最大残留量 (MRL).
- 更新对napropamide的消费者风险评估.
主要方法:
- 提交了一项新的葡萄存储稳定性研究.
- 对提交的数据与已识别的数据差距进行评估.
- 根据新信息修订临时的MRL.
- 更新了长期暴露的消费者风险评估.
主要成果:
- 只有葡萄的储存稳定性研究得到了令人满意的解决.
- 代谢,残留试验和分析方法数据缺口仍然存在.
- 对特定商品的临时MRL进行了修订.
- 更新的消费者风险评估表明没有慢性暴露问题.
结论:
- 评估解决了napropamide的特定数据缺口,导致修订了MRL.
- 尽管仍有数据缺口,但消费者风险被认为是可以接受的.
- 为了进行全面的评估,可能需要进一步的数据.
更多相关视频
08:59An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
Published on: December 3, 2020
8.0K
13:35A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites
Published on: March 1, 2018
14.7K
相关概念视频
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Pharmacovigilance
895
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
895
